(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-13 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1516148
Date | Daily Closing Price | Open | High | Low | Volume |
13 Tue Aug 2024 | 48.22 | 47.10 | 48.50 | 46.57 | 0.62 times |
12 Mon Aug 2024 | 46.91 | 47.04 | 47.65 | 46.05 | 0.65 times |
09 Fri Aug 2024 | 47.01 | 48.26 | 49.19 | 46.57 | 0.655 times |
08 Thu Aug 2024 | 47.86 | 47.55 | 48.46 | 46.65 | 0.812 times |
07 Wed Aug 2024 | 47.27 | 50.46 | 50.46 | 46.90 | 1.055 times |
06 Tue Aug 2024 | 49.33 | 50.21 | 51.11 | 48.00 | 1.041 times |
05 Mon Aug 2024 | 49.66 | 44.95 | 50.18 | 44.80 | 1.672 times |
02 Fri Aug 2024 | 51.11 | 53.00 | 53.15 | 49.73 | 1.687 times |
01 Thu Aug 2024 | 54.85 | 57.39 | 57.68 | 54.62 | 0.899 times |
31 Wed Jul 2024 | 57.29 | 56.73 | 59.50 | 56.02 | 0.68 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 49.1, but if it comes above 49.1, then a intra day buy could be more profitable.
If you take a sell trade below 49.1, then use 49.1 as stoploss and 43.8 as target. However if you take a buy trade in stock , then use 49.1 as stoploss and 53.5 as target.
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 44.80 |
Downside Target | 46.05 |
Upside Target | 48.50 |
Upside Target | 49.73 |
Upside Target | 51.02 |
Upside Target | 52.31 |
Upside Target | 57.68 |
Upside Target | 59.18 |
Upside Target | 59.50 |
Upside Target | 59.77 |
Upside Target | 63.68 |
Upside Target | 67.88 |
Upside Target | 68.39 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 46.68 |
Downside Intraday Target | 45.14 |
Upside Intraday Target | 49.13 |
Upside Intraday Target | 50.04 |
Downside Intraday Target | 47.59 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
13 Tue Aug 2024 | 48.22 | 47.04 | 48.50 | 46.05 | 0.243 times |
09 Fri Aug 2024 | 47.01 | 44.95 | 51.11 | 44.80 | 1.127 times |
02 Fri Aug 2024 | 51.11 | 57.95 | 59.50 | 49.73 | 1.36 times |
26 Fri Jul 2024 | 57.92 | 55.20 | 59.77 | 54.06 | 0.573 times |
19 Fri Jul 2024 | 54.56 | 57.95 | 63.68 | 54.01 | 1.45 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
13 Tue Aug 2024 | 48.22 | 57.39 | 57.68 | 44.80 | 0.486 times |
31 Wed Jul 2024 | 57.29 | 54.02 | 63.68 | 52.31 | 0.995 times |
28 Fri Jun 2024 | 54.01 | 54.82 | 67.88 | 53.33 | 1.023 times |
31 Fri May 2024 | 53.74 | 53.16 | 59.18 | 51.02 | 0.974 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.02 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.02 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.